WEST PHARMACEUTICAL SERVICES INC (WST)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for WST
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| WST | Retired Chair, President & Chief Executive Officer, PerkinElmer, Inc. (now Revvity, Inc.); Lead Independent Director; Chair of the Board of Directors | 70 | ["Retired Chair, President & Chief Executive Officer, PerkinElmer, Inc.","Comprehensive healthcare industry experience","Leadership in setting growth strategy and overseeing operational and financial risks","Finance and tax expertise","Experience with mergers, acquisitions and strategic partnerships","Service on other Boards"] | ["CC","Nominating & Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| XYL | Director; Former Chairman, President & CEO, PerkinElmer Inc. | 70 | ["Chief Executive Officer of PerkinElmer, Inc.", "Executive Vice President & Chief Financial Officer at PerkinElmer", "President of Life and Analytical Sciences at PerkinElmer", "President & Chief Operating Officer at PerkinElmer", "Vice President & Treasurer at AlliedSignal, Inc.", "Experience in global technology companies", "Expertise in leadership development, risk management, corporate governance", "Chair", "CEO/C-Suite", "Financial Expert", "Global Business", "Growth", "Public Co. Board", "Relevant Industry Expertise", "Risk Management", "Strategy", "Technology & Innovation"] | ["Leadership Development & Compensation", "Chair"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Friel brings to the Board comprehensive healthcare industry experience through his leadership of PerkinElmer, where he served as Chair, Chief Executive Officer, Chief Operating Officer and Chief Financial Officer (1999 2019). Prior to joining PerkinElmer, Mr. Friel served in several finance-focused senior management positions with AlliedSignal, Inc., now Honeywell International. His extensive global leadership in setting growth strategy and overseeing operational and financial risks strengthens the Board s global perspective. Mr. Friel s deep finance and tax expertise and his experience with mergers, acquisitions and strategic partnerships support his service on the Board s Nominating & Corporate Governance Committee. Mr. Friel s tenured leadership at a successful public company and service on other Boards enhance our Board s oversight of succession planning, innovation and corporate governance. Mr. Friel is a director of New York Life Insurance Company.